About The Position

Sanofi is seeking a highly motivated Summer Intern to join its Immunology New Product Launch team in Cambridge, Massachusetts. The recently established team supports early commercial planning for pipeline assets and helps prepare the company and market for potential treatment options for immunological diseases across dermatology, respiratory, rheumatology, and gastroenterology. The intern will work with global brand teams and the New Product Launch commercial team on preliminary U.S. brand planning for late-stage clinical assets, including rilzabrutinib and duvakitug. The role also involves therapeutic-area competitor analysis, market access assessment and early forecasting, and participation in market research to identify insights gaps. The internship lasts 10–12 weeks. The intern must be enrolled at an accredited college or university throughout the internship, be able to relocate to the office location, and work 40 hours per week, Monday through Friday, for the full duration. The listed compensation is $58 USD per hour, with final compensation determined based on demonstrated experience.

Requirements

  • Currently pursuing an MBA.
  • Permanently authorized to work in the United States without requiring employment visa sponsorship at the time of application or in the future.
  • Enrolled in an accredited college or university throughout the internship.
  • Able to relocate to the office location and work 40 hours per week, Monday through Friday, for the full internship duration.

Nice To Haves

  • Strategic thinking.
  • Cross-functional teamwork and collaboration.
  • Project management.
  • Strong communication and presentation skills.

Responsibilities

  • Work with global brand teams and the New Product Launch commercial team to support development of a preliminary U.S. brand plan for late-stage clinical assets, including rilzabrutinib and duvakitug.
  • Complete a competitor analysis in at least one of the following therapeutic areas: asthma, chronic spontaneous urticaria (CSU), IgG4-related disease (IgG4-RD), ulcerative colitis, or Crohn’s disease.
  • Evaluate and summarize current treatments, existing competitors, therapies in development, available resources, and patient support programs.
  • Support market access assessment and early forecasting efforts to scenario-plan launch strategies.
  • Participate in market research projects and help identify insights gaps for future planning.

Benefits

  • Mentoring and guidance from inspirational leaders.
  • Access to apprenticeships, internships, graduate programs, and international experiences.
  • Access to the latest tools, digital innovation, and continuous learning.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service